TELTARTAN HCT 40/12.5 mg telmisartan 40 mg & hydrochlorothiazide 12.5 mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

teltartan hct 40/12.5 mg telmisartan 40 mg & hydrochlorothiazide 12.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - telmisartan, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet, multilayer - excipient ingredients: magnesium stearate; purified water; povidone; sodium stearylfumarate; mannitol; sodium hydroxide; meglumine; lactose monohydrate; iron oxide red - teltartan hct is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

AVSARTAN HCT 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

avsartan hct 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablets blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: povidone; polysorbate 80; sodium starch glycollate type b; hypromellose; colloidal anhydrous silica; magnesium stearate; mannitol; iron oxide red; iron oxide yellow; titanium dioxide; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AVSARTAN HCT 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

avsartan hct 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablets blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: povidone; hypromellose; colloidal anhydrous silica; mannitol; polysorbate 80; sodium starch glycollate type b; magnesium stearate; titanium dioxide; iron oxide yellow; iron oxide red; carnauba wax; macrogol 3350 - indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AVAPRO HCT 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

avapro hct 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; silicon dioxide; croscarmellose sodium; hypromellose; carnauba wax; magnesium stearate; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - avapro hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

AVAPRO HCT 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

avapro hct 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: carnauba wax; lactose monohydrate; magnesium stearate; hypromellose; croscarmellose sodium; silicon dioxide; microcrystalline cellulose; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - avapro hct is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

KARVEZIDE 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

karvezide 300/12.5 irbesartan 300 mg and hydrochlorothiazide 12.5 mg tablet blister pack

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; lactose monohydrate; silicon dioxide; croscarmellose sodium; magnesium stearate; carnauba wax; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - karvezide is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

KARVEZIDE 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

karvezide 150/12.5 irbesartan 150 mg and hydrochlorothiazide 12.5 mg tablet blister pack

sanofi-aventis australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 150 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; carnauba wax; magnesium stearate; silicon dioxide; microcrystalline cellulose; hypromellose; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 3000 - karvezide is indicated for the treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

ALEMBIC OLMESARTAN HCT 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

alembic olmesartan hct 20/12.5 olmesartan medoxomil/hydrochlorothiazide 20/12.5 mg film-coated tablet blister pack

alembic pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hypromellose; lactose monohydrate; purified water; magnesium stearate; hyprolose; titanium dioxide; iron oxide yellow; macrogol 4000 - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

ALEMBIC OLMESARTAN HCT 40/12.5 olmesartan medoxomil/hydrochlorothiazide 40/12.5 mg film-coated tablet blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

alembic olmesartan hct 40/12.5 olmesartan medoxomil/hydrochlorothiazide 40/12.5 mg film-coated tablet blister pack

alembic pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; hypromellose; microcrystalline cellulose; hyprolose; purified water; titanium dioxide; iron oxide yellow; macrogol 4000 - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

AMBOTENS HCT 300/12.5 irbesartan hydrochlorothiazide 300/12.5 mg tablets blister pack Australija - anglų - Department of Health (Therapeutic Goods Administration)

ambotens hct 300/12.5 irbesartan hydrochlorothiazide 300/12.5 mg tablets blister pack

medis pharma pty ltd - hydrochlorothiazide, quantity: 12.5 mg; irbesartan, quantity: 300 mg - tablet, film coated - excipient ingredients: mannitol; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; povidone; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - treatment of hypertension. treatment should not be initiated with this fixed dose combination.